A detailed history of Bivin & Associates, Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Bivin & Associates, Inc. holds 3,640 shares of BDX stock, worth $826,098. This represents 0.96% of its overall portfolio holdings.

Number of Shares
3,640
Previous 3,679 1.06%
Holding current value
$826,098
Previous $979,000 8.38%
% of portfolio
0.96%
Previous 0.89%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$234.74 - $275.42 $9,154 - $10,741
-39 Reduced 1.06%
3,640 $897,000
Q1 2022

May 06, 2022

SELL
$243.64 - $270.48 $135,463 - $150,386
-556 Reduced 13.13%
3,679 $979,000
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $974,388 - $1.06 Million
4,235 New
4,235 $1.07 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.7B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Bivin & Associates, Inc. Portfolio

Follow Bivin & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bivin & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bivin & Associates, Inc. with notifications on news.